Clair Scientific ApSAktiv
Økonomiske nøgletal
Nøgletal
2025Balancens sammensætning
Selskabsskat
indkomstår 2024Kilde: Skattestyrelsens offentlige skattelister for selskaber. Beregnet skat for indkomståret; kan være lavere end 22 % af indkomsten, fx ved skat betalt i udlandet. sktst.dk
Regnskabstal2023–2025
| 2023 | 2024 | 2025 | |
|---|---|---|---|
| Balance — aktiver | |||
| Likvide beholdninger | 71.267 | 10.481.688 | 4.980.201 |
| Omsætningsaktiver i alt | 301.340 | 10.990.718 | 6.180.288 |
| Anlægsaktiver i alt | 76.500 | 1.880.840 | 3.774.687 |
| Aktiver i alt | 377.840 | 12.871.558 | 9.954.975 |
| Balance — passiver | |||
| Kortfristede gældsforpligtelser | 225.653 | 218.485 | 394.678 |
| Langfristede gældsforpligtelser | — | — | — |
| Gældsforpligtelser i alt | 225.653 | 218.485 | 394.678 |
| Selskabskapital | 40.000 | 53.894 | 53.894 |
| Overført resultat | 88.187 | 10.779.539 | 6.580.017 |
| Årets resultat | 88.188 | 569.762 | -2.740.608 |
| Egenkapital i alt | 152.187 | 12.252.752 | 9.512.144 |
| Resultatopgørelse | |||
| Bruttofortjeneste | 384.263 | 2.001.682 | 241.541 |
| Resultat af primær drift | 114.280 | 682.311 | -3.569.093 |
| Resultat før skat | 113.620 | 689.748 | -3.559.817 |
| Årets resultat | 88.188 | 569.762 | -2.740.608 |
| Personaleomkostninger | 269.983 | 1.319.371 | 3.810.634 |
| Af- og nedskrivninger | — | — | — |
| Andre nøgletal | |||
| Ansatte | — | 2 | 6 |
En streg (—) betyder, at der ikke er indsendt årsrapport, eller at posten ikke fremgår af den; 0 er et nul angivet i årsrapporten.
Om virksomheden
Årsrapport 2025Description of key activities of the companyClair Scientific develops and commercializes quantitative phase imaging (QPI) microscopy systems and software for non-destructive measurement and analysis of biological samples and materials. The company's core technology platform enables label-free, high-resolution phase imaging of living cells, tissues, and other specimens. Primary applications include research in cell biology and biophysics, pre-clinical and quality assurance workflows in pharmaceutical and life science manufacturing, and emerging applications in materials science and industrial quality control. The company sells microscope systems, accessories, and related services to academic institutions, contract research organizations, and commercial partners. Product development, technical support, and go-to-market activities constitute the primary operational focus.
Significant changes in the company's activities and financial mattersThe gross profit for the year totals DKK 242thousand against DKK 2.002thousand last year. Profit or loss from ordinary activities after tax totals DKK -2.741thousand against DKK 570thousand last year. Management considers the net profit or loss for the year satisfactory.
Uddrag af ledelsesberetningen i den seneste årsrapport.